Skip to content

Clinical trials

Phase 3 Brain Neoplasms trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Brain Neoplasms Phase: Phase 3 Country / region: United Kingdom Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20042
20062
20081
20091
20111
20151
20163
20212
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Active, not recruiting3
Terminated3
Unknown status2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC4
Bristol-Myers Squibb2
Spectrum Pharmaceuticals, Inc2
AbbVie1
AstraZeneca1
Celldex Therapeutics1
HUYABIO International, LLC.1
Health Clinics Limited1
INSYS Therapeutics Inc1
Institute of Cancer Research, United Kingdom1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Brain Neoplasms21
Glioblastoma7
Neoplasm Metastasis7
Glioma5
Breast Neoplasms4
Neoplasms4
Astrocytoma3
Gliosarcoma3
Central Nervous System Neoplasms2
Melanoma2

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.